CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer Cure

GlobeNewswire•November 14, 2018 OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer. Bringing his expertise in venture capital, Katz will oversee the company’s financial functions and investment relations. “Our company is approaching…